Sub menu

 
 

Arrow Pharma - Ferrogen

Therapeutic Goods Act 1989

Approval under section 42DF for use of restricted representations by Arrow Pharma Pty Ltd

I, Leanne McCauley, Delegate of the Secretary to the Department of Health, on receipt of an application from Arrow Pharma Pty Ltd, have approved under section 42DF of the Therapeutic Goods Act 1989 the restricted representations specified in column 2 of the table below for use in advertisements specified in column 3 about the therapeutic goods specified in column 4:

Approved use of restricted representation
Column 1Column 2Column 3Column 4
ItemRestricted representationAdvertisementTherapeutic goods
1"For the prevention and treatment of medically diagnosed iron deficiency anaemia"

an advertisement about the therapeutic goods specified in column 4 including, but not limited to, an advertisement that is:

  1. on the label of the therapeutic goods; or
  2. in information included in the package in which the therapeutic goods are contained
FERROGEN ferrous sulphate 325mg tablets bottle pack (AUST R 329944)
2"For the prevention and treatment of medically diagnosed iron deficiency"

an advertisement about the therapeutic goods specified in column 4 including, but not limited to, an advertisement that is:

  1. on the label of the therapeutic goods; or
  2. in information included in the package in which the therapeutic goods are contained
FERROGEN IRON + VITAMIN C modified release tablets (AUST R 329167)
3"For the prevention and treatment of iron deficiency anaemia"

an advertisement about the therapeutic goods specified in column 4 that is:

  1. on the label of the therapeutic goods; or
  2. in information included in the package in which the therapeutic goods are contained
FERROGEN ferrous sulphate 325mg tablets bottle pack (AUST R 329944)
4"For the prevention and treatment of iron deficiency, with vitamin C"

an advertisement about the therapeutic goods specified in column 4 that is:

  1. on the label of the therapeutic goods; or
  2. in information included in the package in which the therapeutic goods are contained
FERROGEN IRON + VITAMIN C modified release tablets (AUST R 329167)

Dated this day 3 June 2020

Signed electronically

Leanne McCauley
Delegate of the Secretary to the Department of Health
Advertising Compliance Unit
Regulatory Compliance Branch

Print version

Last updated

Help us improve the Therapeutic Goods Administration site